SportsNCT01727479
Ribose and Sport Performance
A study testing Ribose in people with Sports, run by Laval University at 1 site in Canada.
Trial summary
Investigate the acute effect of ribose supplementation on performance and recovery in athletes. Read more about this study
- Who is it for?
- Ages 18 to 50 yearsHealthy volunteers can take part
- Conditions the study is for
- Sports
- What is being tested?
- Ribose
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 18 participants
- Where
- 1 siteCanada
- Study dates
- Aug 2012to Jan 2013
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 50 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Men and women
- Training volume > 7hrs/week
- VO2 max > 40 and 45 mg/kg/min (for women and men respectively)
- Otherwise healthy individuals
Who cannot join
- Pregnant or breastfeeding women
- Individuals with endocrine disorders, hypercholesterolemia, cardiovascular diseases, gut diseases, cancer, anemia, hypoglycemia
- Medication for lipids, diabetes, hypertension, inflammation, autoimmune diseases, mood disorders
- Excessive alcohol consumption (more than two drinks by day for men, one for women), smoking, drug use, supplements or natural products consumption during the study
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Effect of Ribose on Performance and Recovery in Athletes
Investigate the acute effect of ribose supplementation on performance and recovery in athletes.
- Conditions
- Sports
- Being tested
- Ribose, Placebo
- Keywords
- Peak VO2 consumption, 3km time trial, fatigue perception, lactate, time to complete
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
RiboseOther
After each of the 3km time trial (3 in total), participants will be asked to drink the experimental product (or placebo) incorporated in a sports drink.
PlaceboOther
| Study group | Role | What they receive |
|---|---|---|
| Ribose | Experimental | After each of the 3km time trial (3 in total), consumption of ribose incorporated in a sports drink. Receives: Other: Ribose |
| Placebo | Placebo comparator | After each of the 3km time trial (3 in total), consumption of placebo incorporated in a sports drink. Receives: Other: Placebo |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in time to complete the third of 3 consecutive 3km time trials on bike
Measured: baseline and 1 week
Secondary outcomes (1)
Performance on the 3 consecutive 3km time trials on bike
Performance measures: peak power (watts/kg), mean power (watts/kg), time to peak power (sec), total work (kJ) and maximum cadence (RPMmax)
Measured: baseline and 1 week
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Nov 2012 (estimated)
- Study startAug 2012
- Primary completionJan 2013
- Study completionJan 2013
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for SportsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Triple blind
- Who is masked
- Participant, Investigator, Outcomes assessor
- Enrolment
- 18 participants (actual)
Sponsor and investigators
- Lead sponsor
- Laval University
- Sponsor type
- University, hospital or other
- Collaborators
- Atrium Innovations
- Responsible party
- Sponsor
- Investigators
- Benoît Lamarche, PhD, Principal investigator, Institute on nutraceuticals and functional foods
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01727479
- Sponsor's protocol ID
- 2012-048
- Other IDs
- INAF-2012-048
- Status last verified
- Dec 2016
- First submitted
- 2 Nov 2012
- Last updated
- 5 Dec 2016
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 5 Dec 2016. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Ribose on Performance and Recovery in Athletes
- ClinicalTrials.gov ID
- NCT01727479
- Acronym / sponsor ID
- 2012-048
- Conditions
- Sports
- Keywords
- Peak VO2 consumption, 3km time trial, fatigue perception, lactate, time to complete
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 18 participants (actual)
- Lead sponsor
- Laval UniversityUniversity, hospital or other
- Collaborators
- Atrium Innovations
- Study start
- Aug 2012
- Primary completion
- Jan 2013 (actual)
- Study completion
- Jan 2013 (actual)
- First posted
- 16 Nov 2012 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Investigate the acute effect of ribose supplementation on performance and recovery in athletes.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Triple blind (participant, investigator, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Ribose | Experimental | Other: RiboseAfter each of the 3km time trial (3 in total), consumption of ribose incorporated in a sports drink. |
| Placebo | Placebo comparator | Other: PlaceboAfter each of the 3km time trial (3 in total), consumption of placebo incorporated in a sports drink. |
Who may qualify
- Ages
- 18 to 50 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (4 listed)
- Men and women
- Training volume > 7hrs/week
- VO2 max > 40 and 45 mg/kg/min (for women and men respectively)
- Otherwise healthy individuals
Key exclusion criteria (4 listed)
- Pregnant or breastfeeding women
- Individuals with endocrine disorders, hypercholesterolemia, cardiovascular diseases, gut diseases, cancer, anemia, hypoglycemia
- Medication for lipids, diabetes, hypertension, inflammation, autoimmune diseases, mood disorders
- Excessive alcohol consumption (more than two drinks by day for men, one for women), smoking, drug use, supplements or natural products consumption during the study
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| RiboseAfter each of the 3km time trial (3 in total), participants will be asked to drink the experimental product (or placebo) incorporated in a sports drink. | Other | Ribose |
| Placebo | Other | Placebo |
Primary outcome
Change in time to complete the third of 3 consecutive 3km time trials on bike
Time frame: baseline and 1 week
1 secondary outcome
Performance on the 3 consecutive 3km time trials on bike
Time frame: baseline and 1 week
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Dec 2016.
Related trials for Sports
Active, not recruiting
Quiet Eye Duration in Baseball
Gaze Tracking
Not yet recruiting
Comparison Between Eccentric Hamstring Training and Sprint-Specific Training
Healthy Adult, Athlete
RecruitingObservational study
Cryopreserved Hair Follicles for Disease and Cell Replacement
Diabetes Mellitus, Sport Injury
Recruiting
Effects of Scapular Training on Adolescent Boxers
Sports Physical Therapy
Enrolling by invitation
Recovery Modalities and Application Sequence in Elite Female Basketball Players
Basketball, Basketball Performance
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Benoît Lamarche, PhD principal investigator
Institute on nutraceuticals and functional foods
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Ribose in people with Sports, run by Laval University at 1 site in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 5 Dec 2016. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in time to complete the third of 3 consecutive 3km time trials on bike (time frame: baseline and 1 week). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Dec 2016.